Dendritic cell therapy for cancers and underlying mechanisms involved in cancer development
Dendritic cells (DCs) are the most potent antigen-presenting cells (APCs) that affect prime naive T cells and create proper immune responses. The uncontrolled growth of cancer cells often results from the cell’s successful inhibition of cytotoxic T lymphocytes. In addition to conventional cancer tr...
Main Authors: | Thi Xuan Nguyen, Huy Hoang Nguyen |
---|---|
Format: | Article |
Language: | English |
Published: |
Vietnam Ministry of Science and Technology
2017-06-01
|
Series: | Vietnam Journal of Science, Technology and Engineering |
Subjects: | |
Online Access: | https://vietnamscience.vjst.vn/index.php/vjste/article/view/308 |
Similar Items
-
Editorial: Harnessing the Participation of Dendritic Cells in Immunity and Tolerance
by: Silvia Beatriz Boscardin, et al.
Published: (2020-10-01) -
Molecular and cell-biological mechanisms of antigen cross-presentation
by: Christian eKurts
Published: (2013-02-01) -
A Discrete Subset of Monocyte-Derived Cells among Typical Conventional Type 2 Dendritic Cells Can Efficiently Cross-Present
by: Sheng, Jianpeng, et al.
Published: (2018) -
Current state and prospects of using dendritic cell vaccination for cancer immunotherapy
by: I.Yu. Filin, et al.
Published: (2022-09-01) -
The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
by: Kalijn F. Bol, et al.
Published: (2019-04-01)